MTOR and neoplasm with perivascular epithelioid cell differentiation: Interestingly, in a retrospective case series published in 2018, seven patients with advanced PEComa progressing on mTOR inhibitor (sirolimus) were treated with exemestane, an aromatase inhibitor, in combination with everolimus.